Live Breaking News & Updates on Gild

Stay informed with the latest breaking news from Gild on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Gild and stay connected to the pulse of your community

Gilead Sciences, Inc. Forecasted to Earn Q1 2024 Earnings of ($1.42) Per Share (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) – Equities researchers at Zacks Research decreased their Q1 2024 EPS estimates for Gilead Sciences in a report released on Tuesday, April 23rd. Zacks Research analyst E. Bagri now anticipates that the biopharmaceutical company will post earnings of ($1.42) per share for the quarter, down from their prior […]

United-states , Merdad-parsey , Complera-eviplera , Altfest-lj-co , Nasdaq , Gilead-sciences , Hermes-inc , Wetzel-investment-advisors-inc , Gilead-sciences-increases-dividend , Gilead-sciences-inc , Wells-fargo-company , Gilead-sciences-stock-performance

Gilead Sciences Target of Unusually Large Options Trading (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) was the recipient of unusually large options trading activity on Thursday. Investors bought 42,588 put options on the stock. This represents an increase of 240% compared to the average volume of 12,513 put options. Gilead Sciences Trading Down 2.3 % Shares of NASDAQ:GILD traded down $1.53 during […]

Canada , United-states , Merdad-parsey , Complera-eviplera , Gilead-sciences-trading-down , Gilead-sciences-inc , Gilead-sciences-increases-dividend , Gilead-sciences , News-ratings-for-gilead-sciences-daily , Wetzel-investment-advisors-inc , Hedge-funds-weigh-in-on-gilead-sciences , Nasdaq

Parkside Financial Bank & Trust Acquires 165 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Parkside Financial Bank & Trust grew its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 5.7% in the 4th quarter, HoldingsChannel.com reports. The fund owned 3,063 shares of the biopharmaceutical company’s stock after purchasing an additional 165 shares during the quarter. Parkside Financial Bank & Trust’s holdings in Gilead Sciences were worth $248,000 […]

United-states , Complera-eviplera , Merdad-parsey , Gilead-sciences , Securities-exchange-commission , Parkside-financial-bank , News-ratings-for-gilead-sciences-daily , Wells-fargo-company , Nasdaq , Fortitude-family-office , Gilead-sciences-price-performance , Gilead-sciences-increases-dividend

Parkside Financial Bank & Trust Has $248,000 Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Parkside Financial Bank & Trust raised its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 5.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,063 shares of the biopharmaceutical company’s stock after acquiring an additional 165 shares […]

Canada , United-states , Complera-eviplera , Merdad-parsey , Cantor-fitzgerald , Nasdaq , News-ratings-for-gilead-sciences-daily , Wells-fargo-company , Parkside-financial-bank , Gilead-sciences , Exchange-commission , Tompkins-financial-corp

Illinois Municipal Retirement Fund Sells 79,102 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Illinois Municipal Retirement Fund lowered its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 24.8% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 239,358 shares of the biopharmaceutical company’s stock after selling 79,102 shares during the quarter. Illinois Municipal Retirement […]

United-states , Illinois , Canada , Merdad-parsey , Complera-eviplera , Gilead-sciences , Clearbridge-investments , Morgan-stanley , Capital-management , Quarter-for-gilead-sciences , Northern-trust-corp , Insider-transactions-at-gilead-sciences

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by OLD National Bancorp IN

OLD National Bancorp IN lowered its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 3.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 22,718 shares of the biopharmaceutical company’s stock after selling 802 shares during the quarter. OLD […]

United-states , Complera-eviplera , Merdad-parsey , Gilead-sciences , Clearbridge-investments , Barclays , National-bancorp , Gilead-sciences-inc , Nasdaq , Gilead-sciences-company-profile , Gilead-sciences-increases-dividend , Cantor-fitzgerald

Sage Mountain Advisors LLC Has $301,000 Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Sage Mountain Advisors LLC grew its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 10.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 3,717 shares of the biopharmaceutical company’s stock after purchasing an additional 345 shares during the quarter. […]

United-states , Canada , Complera-eviplera , Merdad-parsey , Global-retirement-partners , Royal-bank , Insider-transactions-at-gilead-sciences , Nasdaq , Gilead-sciences , Wells-fargo-company , News-ratings-for-gilead-sciences-daily , Third-wealth-advisors

PDS Planning Inc Has $359,000 Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

PDS Planning Inc raised its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 4.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,426 shares of the biopharmaceutical company’s stock after buying an additional 182 shares during […]

United-states , Canada , Complera-eviplera , Merdad-parsey , Gilead-sciences-increases-dividend , Etesian-wealth-advisors-inc , Exchange-commission , Planning-inc , Financial-counselors-inc , Gilead-sciences , Nilsine-partners , Securities-exchange-commission

Commerzbank Aktiengesellschaft FI Takes Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Commerzbank Aktiengesellschaft FI bought a new stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 4,656 shares of the biopharmaceutical company’s stock, valued at approximately $378,000. Several other institutional investors and hedge funds have […]

Canada , United-states , Merdad-parsey , Complera-eviplera , News-ratings-for-gilead-sciences-daily , Financial-connections-group-inc , Gilead-sciences , Fortitude-family-office , Rakuten-securities-inc , Exchange-commission , Gilead-sciences-company-profile , Gilead-sciences-inc

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Kornitzer Capital Management Inc. KS

Kornitzer Capital Management Inc. KS decreased its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 0.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 375,325 shares of the biopharmaceutical company’s stock after selling 1,170 shares during the quarter. […]

United-states , Complera-eviplera , Merdad-parsey , Barclays , Gilead-sciences-inc , Gilead-sciences-increases-dividend , Investment-advisory-services-inc , Kornitzer-capital-management-inc , Tompkins-financial-corp , Gilead-sciences , Wells-fargo-company , Quarter-for-gilead-sciences